More Immutep Ltd news Immutep LtdASX: IMM Initiation of Ph 2/3 Trial for Metastatic Breast Cancer Mar 14, 2023 at 1:31 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
